En­deit Cap­it­al in­vests in lux­ury watch start-up Chronext with aid of CMS

12/01/2018

Cologne – Venture capital investor Endeit Capital has taken a stake in Chronext AG, an up-and-coming online portal for luxury watches.

A cross-border team led by Dr Malte Bruhns and Dr Stephan Werlen advised Endeit Capital on legal aspects of the transaction. Alongside Endeit Capital and Tengelmann Ventures, the existing investors – which include Partech Ventures, Capnamic Ventures and Octopus Ventures – also took part in the round of financing, which raised a total of USD 34 million.

CMS has acted for Endeit Capital several times in the past.

Endeit Capital is a VC investor based in Amsterdam and Hamburg that provides growth capital to young technology companies.

E-commerce firm Chronext was founded in 2013 and specialises in buying and selling luxury watches plus offering associated services.

CMS Germany

Dr Malte Bruhns, Lead Partner
Stephan Weling, Senior Associate, both Corporate/M&A

CMS Switzerland

Dr Stephan Werlen, Partner, Corporate/M&A

Press Contact
[email protected] 

Related people

Dr Stephan Werlen
Dr Stephan Werlen, LL.M.
Partner
Zurich
Malte Bruhns
Dr. Malte Bruhns, LL.M. (Edinburgh)
Partner
Cologne
Stephan Weling
Stephan Weling
Senior Associate
Cologne